11 Drug-induced and toxic granulomatous hepatitis

https://doi.org/10.1016/0950-3528(88)90012-7Get rights and content

Abstract

The ability to induce granulomatous hepatitis has been attributed to numerous drugs; some sixty causative drugs have been culled from the literature for this review. Additionally, granulomas or granulomatoid lesions have resulted from occupational exposure to toxic substances (e.g. silica, copper sulphate, beryllium compounds), and particulate material from various therapeutic or diagnostic procedures (e.g. reactions to starch, talc, suture material, polyvinyl pyrrolidone, silicone, barium sulphate, thorium dioxide) or from intravenous drug abuse (e.g. talc). Clinically, patients with drug-induced or toxic granulomatous hepatitis may be asymptomatic. More frequently, the presentation is that of an acute febrile illness, with or without a rash and eosinophilia, followed by jaundice and biochemical evidence of hepatic dysfunction. The diagnosis of drug-induced granulomatous hepatitis is based largely on ruling out other aetiologies. Liver biopsy plays a key role in diagnosis. Recovery is the rule following withdrawal of the drug. Morphologically, drug-induced granulomas may be impossible to distinguish from those due to other causes. Associated lesions suggesting a drug aetiology include significant tissue eosinophilia, unicellular hepatocytic degeneration and necrosis, cholestasis and acute cholangitis or vasculitis. Special stains, polarizing and phase contrast microscopy, transmission and scanning electron microscopy and energy dispersive X-ray microanalysis all play a role in the aetiologic diagnosis of some types of granulomas.

References (97)

  • F Simmons et al.

    Granulomatous hepatitis in a patient receiving allopurinol

    Gastroenterology

    (1972)
  • M Vanderstigel et al.

    Allopurinol hypersensitivity syndrome as a cause of hepatic doughnut-ring granulomas

    Gastroenterology

    (1986)
  • MJ Ahern et al.

    Granulomatous hepatitis and seatone

    Medical Journal of Australia

    (1980)
  • FH Al-Kawas et al.

    Allopurinol hepatotoxicity

  • HW Altmann

    Morphological changes in the liver due to phenazone and its derivatives

    Agents Actions

    (1986)
  • CW Aungst et al.

    Complications of BCG vaccination in neoplastic disease

    Annals of Internal Medicine

    (1975)
  • SE Benjamin et al.

    Phenylbutazone liver injury: a clinical pathologic survey of 23 cases and review of the literature

    Hepatology

    (1981)
  • JMB Bloodworth

    Morphologic changes associated with sulfonylurea therapy

    Metabolism

    (1963)
  • JMB Bloodworth et al.

    Histopathologic lesions associated with sulfonylurea administration

    Diabetes

    (1961)
  • TD Boyer et al.

    Allopurinol hypersensitivity vasculitis and liver damage

    Western Journal of Medicine

    (1977)
  • DA Bramlet et al.

    Granulomatous hepatitis as a manifestation of quinidine hypersensitivity

    Archives of Internal Medicine

    (1980)
  • Case Records of the Massachusetts General Hospital

    New England Journal of Medicine

    (1962)
  • T Chajek et al.

    Quinidine-induced granulomatous hepatitis

    Annals of Internal Medicine

    (1974)
  • SK Chawla et al.

    Allopurinol hepatotoxicity

    Arthritis and Rheumatism

    (1977)
  • LF Cook et al.

    Phenytoin induced granulomatous hepatitis

    Australian and New Zealand Journal of Medicine

    (1981)
  • CS Davidson et al.

    Guidelines for Detection of Hepatotoxicity due to Drugs and Chemicals

    (1978)
  • T Davion et al.

    Acute hepatitis due to carbamazepine (Tegretol)

  • HP Dincsoy et al.

    Lipogranulomas in non-fatty human livers: a mineral oil induced environmental disease

    American Journal of Clinical Pathology

    (1982)
  • E Dordal et al.

    Fatal halothane hepatitis with transient granulomas

    New Zealand Journal of Medicine

    (1970)
  • JA Ecker

    Phenylbutazone hepatitis

    American Journal of Gastroenterology

    (1965)
  • R Ellenbogen et al.

    Injectable fluid silicone therapy

  • CR Espiritu et al.

    Granulomatous hepatitis associated with sulfadimethoxine hypersensitivity

    Journal of the American Medical Association

    (1967)
  • CR Espiritu et al.

    Pronestyl induced granulomatous hepatitis

    Gastroenterology

    (1977)
  • CR Espiritu et al.

    Allopurinol-induced granulomatous hepatitis

    Digestive Diseases and Sciences

    (1976)
  • A Fich et al.

    Sulfasalazine hepatotoxicity

    American Journal of Gastroenterology

    (1984)
  • R Fournier et al.

    Hépatite au maleate de nomifensine

    Médicine et Chirurgie Digestive

    (1984)
  • CM Gaffey et al.

    Phenytoin-induced systemic granulomatous vasculitis

    Archives of Pathology and Laboratory Medicine

    (1986)
  • G Goldstein

    Sarcoid reaction associated with phenylbutazone hypersensitivity

    Annals of Internal Medicine

    (1963)
  • H Gormsen

    On the occurrence of epitheloid cell granulomas in the organs of BCGvaccinated human beings

    Acta Pathologica Microbiologica Scandinavica

    (1955)
  • MJ Greene et al.

    Delayed hypersensitivity

  • N Harats et al.

    Gold-induced granulomatous hepatitis

    Israeli Journal of Medical Sciences

    (1985)
  • C Hatzitheofilou et al.

    Granulomas in melanoma patients treated with BCG immunotherapy

    Cancer

    (1982)
  • JC Homberg et al.

    Drug-induced hepatitis with anti-intracytoplasmic organelle autoantibodies

    Hepatology

    (1985)
  • T Hunziker et al.

    Arzneifieber auf das Antidepressivum Nomifensin (Alival)

    Schweizerische Medizinische Wochenschrift

    (1980)
  • M Ingelmo et al.

    Angiitis por hipersensibilidad y hepatitis granulomatosa inducida por glibenclamida: a proposito de un caso

    Medicina Clinica

    (1980)
  • SK Irani et al.

    Hepatic granulomas: A review of 73 patients from one hospital and survey of the literature

    Journal of Clinical Gastroenterology

    (1979)
  • NS Irey

    Tissue reactions to drugs

    American Journal of Pathology

    (1976)
  • KG Ishak et al.

    Granulomas and cholestatic-hepatocellular injury associated with phenylbutazone

  • Cited by (61)

    • Hepatic Injury due to Drugs, Dietary and Herbal Supplements, Chemicals and Toxins

      2023, MacSween's Pathology of the Liver, Eighth Edition
    • Hepatic granulomas: Differential diagnosis

      2018, Practical Hepatic Pathology: A Diagnostic Approach: Second Edition
    • Drugs and Toxins

      2018, MacSween's Pathology of the Liver
    • Granulomatous Hepatitis

      2017, Principles and Practice of Pediatric Infectious Diseases
    View all citing articles on Scopus
    View full text